Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 28;140(21):2193–2227. doi: 10.1182/blood.2022015854

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by The American Society of Hematology.

PMC Copyright notice

Figure 5. — Recurrent genetic lesions in mature NK-cell and T-cell neoplasms with potential therapeutic intervention. Representative histology of entities with frequent genetic lesions potentially amenable to therapeutic intervention are shown on the left. The genetic lesions are presented according to functional groups related to TcR signaling, JAK/STAT pathway, epigenetics, or others. Therapeutic efficacy is supported by clinical trial (a); case reports, small case series, or retrospective analyses (b); or experimental or in silico data (c). AITL, Angioimmunoblastic T-cell lymphoma; ATLL, adult T-leukemia/lymphoma; CTCL, cutaneous T-cell lymphoma; ITLPD-GI, indolent clonal T-cell LPD of the gastrointestinal tract; TFHL-F, TFHL, follicular type; T-PLL, T-cell prolymphocytic leukemia. Sources referenced: ²⁶⁸^,²⁷⁰^,²⁷⁸^,²⁸⁴^,²⁹¹^,²⁹³^,³³⁰^,³³⁸^,³³⁹^,³⁴¹^,³⁴⁵^,⁴⁷⁵^,⁴⁷⁶^,⁴⁷⁷^,⁴⁷⁸^,⁴⁷⁹^,⁴⁸⁰^,⁴⁸¹^,⁴⁸²^,⁴⁸³^,⁴⁸⁴^,⁴⁸⁵^,⁴⁸⁶^,⁴⁸⁷.